The role of protein glycosylation in muscle diseases
Authors:
- 15 April 2022
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (8) , 8037-8049
Abstract
Introduction As a post-translational modification, glycosylation plays vital role in regulating the folding and function of proteins necessary for many biological processes. Unlike glycation, glycosylation is an enzymatic process; glycosyltransferases transfer sugars to proteins, forming glycosidic bonds with amino acid residues on proteins. Changes that interfere with the enzymatic reaction and result in abnormal glycosylation can spatio-temporally affect the balance of glycosylation, leading to disease states. Muscle diseases have been associated with dysfunctional protein glycosylation, and many studies have focused on the pathophysiology underlying this association. This review aims to summarize the research progress on protein glycosylation in the pathogenesis of muscle diseases and provides new insight into the muscle research field. Methods Literatures were reviewed comparatively and data were organized to find information about protein glycosylation and its role in muscle disease. Results Protein glycosylation modification is closely related to the occurrence of muscle diseases. α-DG is a key protein in the study of inherited muscle diseases and has a wide range of glycosylation, including O-linked glycosylation and N-linked glycosylation. Besides, O-GlcNAc glycosylation is an important mechanism of protein glycosylation, helping maintaining the structure and function of skeletal muscle and participating in multiple biological processes. Protein glycosylation is also connected to muscle disease and neurodegenerative diseases, especially Alzheimer’s disease. Conclusions Taken together, better understanding of protein glycosylation and its implication in muscle disease would help provide new perspectives in the prevention and treatment measures for human muscle diseases.Keywords
Funding Information
- Natural Science Foundation of China (82072106)
- Natural Science Foundation of China (32071517)
- Natural Science Basic Research Plan in Shaanxi Province of China (2020JM-100)
- the Shaanxi Provincial Key R&D Program (2018KWZ-10)
This publication has 91 references indexed in Scilit:
- Congenital myasthenic syndromes due to mutations inALG2andALG14Brain, 2013
- Increasing O-GlcNAcylation Level on Organ Culture of Soleus Modulates the Calcium Activation Parameters of Muscle FibersPLOS ONE, 2012
- Altered sodium channel-protein associations in critical illness myopathySkeletal Muscle, 2012
- Localization of O-GlcNAc-modified proteins in neuromuscular diseasesMedical Molecular Morphology, 2012
- Evidence‐based path to newborn screening for duchenne muscular dystrophyAnnals of Neurology, 2012
- Dystroglycanopathies: coming into focusCurrent Opinion in Genetics & Development, 2011
- Mass Spectrometric Determination of IgG Subclass-Specific Glycosylation Profiles in Siblings Discordant for Myositis SyndromesJournal of Proteome Research, 2011
- Aging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway ratsBiogerontology, 2008
- Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion‐body myopathy muscleJournal of Neurochemistry, 2007
- Mechanisms of Disease: congenital muscular dystrophies—glycosylation takes center stageNature Clinical Practice Neurology, 2006